Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population

Table 1 Concordance in the treatment of hepatocellular carcinoma proposed by the Hong Kong liver cancer system and Barcelona clinic liver cancer classification

	BCLC-0	BCLC-A	BCLC-B	BCLC-C	BCLC-D
	(ablation, LR or LT)	(ablation, LR or LT)	(TACE)	(SOR)	(ST)
HKLC-I (ablation, LR or LT)	√	√
HKLC-IIA (ablation, LR or LT)	√	√
HKLC-IIB (LR)	√	√
HKLC-IIIA (TACE)			√
HKLC-IIIB (TACE)			√
HKLC-IVA (SOR)				√
HKLC-IVB (SOR or ST)				√
HKLC-VA (LT)
HKLC-VB (ST)					√

The tick in the table means that there was agreement in the treatment of HCC proposed by the HKLC system and BCLC classification. BCLC: Barcelona clinic liver cancer; HCC: Hepatocellular carcinoma; HKLC: Hong Kong liver cancer; LR: Liver resection; LT: Liver transplantation; ST: Symptomatic treatment; SOR: Sorafenib; TACE: Transarterial chemoembolization.